Initiation and regulation of antibacterial innate immunity

抗菌先天免疫的启动和调节

基本信息

  • 批准号:
    8764810
  • 负责人:
  • 金额:
    $ 48.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-15 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neutrophils (PMNs) are powerful anti-microbial cells that are rapidly mobilized and recruited to infected tissues and sites of tissue damage. Once within tissues, PMNs can deploy many activities to remove pathogens and/or damaged cells. Dysregulation of these events can have severe consequences for the host and contribute to the pathology a variety of diseases, including diabetes, thrombus formation and lupus. It has been increasingly recognized that immune cells generate appropriate responses by integrating a variety signals from receptors through multi-protein platforms, called microclusters. This signal integration has been studied extensively in T cells, but the specific rules of integration and cellular outcomes for one cell type do not necessarily apply to other cells because each cell type plays distinct roles in immunity. How PMNs integrate signals from the host and bacteria to generate the correct response in infected tissues is very poorly understood. This application seeks to uncover and understand critical molecular mechanisms PMNs employ to trigger bactericidal responses, using the bacterial pathogen, Yersinia, and its effector proteins, YopH and YopO. Based on our preliminary data indicating that YopH disrupts integration of signals by inactivating SKAP-2, PRAM-1 and SLP- 76-regulated pathways that emanate from micro-clusters, we will focus on understanding the role of SKAP2 in PMN responses. Our central hypothesis is that YopH and YopO impair PMN responses to bacteria by modulating a SKAP2-dependent system that coordinates the anti-microbial functions of PMNs triggered a variety of different types of receptors. Our aims are (1) to determine the critical functions of YopH in tissu infection; (2) dissect the role of SKAP2 in the anti-microbial responses of PMNs; and (3) understand the effects of YopO on neutrophil signaling after receptor stimulation. Through the proposed research, we expect to contribute a better understanding of the molecular mechanisms critical for PMNs anti-microbial responses. An understanding of how PMNs are inactivated by Yops in infected tissues will reveal the mechanisms by which PMNs deploy their anti-microbial and tissue damaging arsenal and lead to new ways to stop this deployment in auto-immune syndromes.
描述(由申请人提供):中性粒细胞(PMN)是一种强大的抗微生物细胞,可快速动员并募集到感染组织和组织损伤部位。一旦在组织内,PMNs可以部署许多活动以去除病原体和/或受损细胞。这些事件的失调可能对宿主产生严重后果,并导致多种疾病的病理学,包括糖尿病、血栓形成和狼疮。人们越来越认识到,免疫细胞通过多蛋白平台(称为微簇)整合来自受体的各种信号来产生适当的反应。这种信号整合已经在T细胞中进行了广泛的研究,但是一种细胞类型的特定整合规则和细胞结果不一定适用于其他细胞,因为每种细胞类型在免疫中起着不同的作用。PMNs如何整合来自宿主和细菌的信号,以在感染组织中产生正确的反应,目前还知之甚少。本申请旨在揭示和理解关键的分子机制PMNs采用触发杀菌反应,使用细菌病原体,耶尔森氏菌,及其效应蛋白,YopH和YopO。基于我们的初步数据表明,YopH通过灭活SKAP-2,PRAM-1和SLP- 76调节的途径,从微簇发出中断信号的整合,我们将专注于了解SKAP 2在PMN反应中的作用。我们的中心假设是,YopH和YopO通过调节SKAP 2依赖性系统来损害PMN对细菌的反应,SKAP 2依赖性系统协调PMN的抗微生物功能,触发了各种不同类型的受体。我们的目的是(1)确定YopH在组织感染中的关键功能;(2)剖析SKAP 2在PMN的抗微生物应答中的作用;以及(3)了解YopO在受体刺激后对中性粒细胞信号传导的影响。通过这项研究,我们希望能够更好地了解PMN抗微生物反应的分子机制。了解感染组织中的Yops如何灭活PMNs将揭示PMNs部署其抗微生物和组织损伤武器库的机制,并导致新的方法来阻止这种部署在自身免疫综合征中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joan C Mecsas其他文献

Joan C Mecsas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joan C Mecsas', 18)}}的其他基金

Dissecting Yersinia Yop Targets in Neutrophils
解析中性粒细胞中的耶尔森氏菌 Yop 靶标
  • 批准号:
    10570181
  • 财政年份:
    2022
  • 资助金额:
    $ 48.15万
  • 项目类别:
A tunable 3D human small intestinal tissue model for study of enteric pathogens
用于研究肠道病原体的可调 3D 人体小肠组织模型
  • 批准号:
    9222476
  • 财政年份:
    2017
  • 资助金额:
    $ 48.15万
  • 项目类别:
A tunable 3D human small intestinal tissue model for study of enteric pathogens
用于研究肠道病原体的可调 3D 人体小肠组织模型
  • 批准号:
    9533472
  • 财政年份:
    2017
  • 资助金额:
    $ 48.15万
  • 项目类别:
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
T3SS针蛋白抑制剂用于治疗铜绿假单胞菌感染
  • 批准号:
    9335269
  • 财政年份:
    2016
  • 资助金额:
    $ 48.15万
  • 项目类别:
T3SS needle protein inhibitors for the treatment of P. aeruginosa infection
T3SS针蛋白抑制剂用于治疗铜绿假单胞菌感染
  • 批准号:
    9046046
  • 财政年份:
    2016
  • 资助金额:
    $ 48.15万
  • 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
  • 批准号:
    8848342
  • 财政年份:
    2014
  • 资助金额:
    $ 48.15万
  • 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
  • 批准号:
    9055639
  • 财政年份:
    2014
  • 资助金额:
    $ 48.15万
  • 项目类别:
Initiation and regulation of antibacterial innate immunity
抗菌先天免疫的启动和调节
  • 批准号:
    9258385
  • 财政年份:
    2014
  • 资助金额:
    $ 48.15万
  • 项目类别:
Inhibitors of Type III Secretion and Translocation in yersinia
耶尔森氏菌 III 型分泌和易位抑制剂
  • 批准号:
    7839596
  • 财政年份:
    2009
  • 资助金额:
    $ 48.15万
  • 项目类别:
Inhibitors of Type III Secretion and Translocation in yersinia
耶尔森氏菌 III 型分泌和易位抑制剂
  • 批准号:
    7681382
  • 财政年份:
    2008
  • 资助金额:
    $ 48.15万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 48.15万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了